@xconomy.com 4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@techcrunch.com 5 years ago
RDMD attacks rare diseases with data mined from health records
@techcrunch.com 5 years ago
With strategic investment, Insilico Medicine is using deep learning to defeat aging